Pfizer's stock price is down materially from its 2021 highs, but it is also up notably from its April 2025 lows.

Pfizer Inc. (NYSE: PFE) made a strong move higher after it became the first drug manufacturer to sign on as part of the ...

A few years ago, Pfizer (NYSE: PFE) saw revenue soar to record heights thanks to coronavirus-related sales, from its vaccine ...

Pfizer delivered strong 2Q25 results with double-digit revenue growth and margin expansion. Click here to read why PFE stock ...

Pfizer, Inc. (NYSE:PFE) shares are trading higher on Tuesday after The Washington Post reported that President Donald Trump ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $29.25, a high estimate of $33.00, and a low estimate of $26.00. Marking an ...

The VanEck Pharmaceutical exchange-traded fund is on a strong run this week [as news of Pfizer's deal with the Trump ...

That brought Pfizer out of the red for the year, with the pharmaceutical firm now sitting at a YTD gain of 2.86%. But are the plans for TrumpRx enough to keep it in the green? And if so, does that ...

Click to open image viewer. The exterior of a 'vaccine shipper,' a container for shipping, and maintaining and tracking the temperature of, the Pfizer-BioNTech COVID-19 vaccine. The cardboard exterior ...